Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Teva announces U.S. FDA approval of three-times-a-week COPAXONE® (glatiramer acetate injection) 40mg/mL
American Academy of Neurology 2012 Annual Meeting
Anti-JC virus antibody prevalence in a multinational multiple sclerosis cohort.
The value of qualitative and quantitative assessment of lesion to cerebral cortex signal ratio on double inversion recovery sequence in the differentiation of demyelinating plaques from non-specific T2 hyperintensities.
Headaches in multiple sclerosis: Cross-sectional study of a multiethnic population.
Cuprizone neurotoxicity in the rat: morphologic observations.
Validation of the Brazilian version of the neurological fatigue index for multiple sclerosis.
Anti-Human Herpesvirus 6A/B IgG Correlates with Relapses and Progression in Multiple Sclerosis.
Remyelination of the superior cerebellar peduncle in the mouse following demyelination induced by feeding cuprizone.
Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β.
Biogen Idec's TECFIDERA™ (dimethyl fumarate) approved in US as a first-line oral treatment for multiple sclerosis
Sequential myelin protein expression during remyelination reveals fast and efficient repair after central nervous system demyelination.
Keystone Symposium: Viral Immunity
Breastfeeding is not related to postpartum relapses in multiple sclerosis.
Episode 34 with Dr. Jill Hollenbach on killer immunoglobulin like (KIR) receptors
Microglia across the lifespan: from origin to function in brain development, plasticity and cognition.
Alemtuzumab improves neurological functional systems in treatment-naive relapsing-remitting multiple sclerosis patients.
Adherence to Disease Modifying Drugs among Patients with Multiple Sclerosis in Germany: A Retrospective Cohort Study.
Cerebrospinal fluid markers reveal intrathecal inflammation in progressive multiple sclerosis.
Demyelination and remyelination in anatomically distinct regions of the corpus callosum following cuprizone intoxication.
MS Frontiers 2015
Immunology 2015
B1 cells are unaffected by immune modulatory treatment in remitting-relapsing multiple sclerosis patients.
American Academy of Neurology Annual Meeting
Episode 32 with Dr. David Holtzman on the connection between MS and Alzheimer 's disease

Pages